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Abstract
Kimura’s disease is a rare, benign, slow growing chronic inflammatory swelling with a predilection for the head and
neck region and almost always with peripheral blood eosinophilia and elevated serum IgE levels. Here, we report a
25-year-old male patient with asthma, Reynaud phenomenon, eosinophilic panniculitis, bilateral inguinal lymphade-
nopathy and peripheral blood eosinophilia.
He responded initially to oral prednisolone with the subsidence of peripheral blood eosinophilia, asthma and the
Reynaud phenomenon. But with tapering of prednisolone symptoms reappeared and hereby he was treated with
cyclosporine. He has been symptom free for 6 months of follow up while taking cyclosporine 25 mg orally per day.
Eosinophilia has resolved. This case shows that in addition to previously reported associations, Kimura disease may
be associated with eosinophilic panniculitis and that cyclosporine could be effective in its treatment.
Background
Kimura’s disease (KD) is a rare, chronic inflammatory
disorder of unknown cause. The most common clinical
feature of this disease is an asymptomatic unilateral
soft-tissue mass in the head and neck. Major salivary
glands and lymph nodes may also be involved. Bilateral
involvement is rare. Patients almost always have marked
peripheral eosinophilia, and elevated serum IgE levels.
Here, we report a 25-year-old male patient with asthma,
Reynaud phenomenon, eosinophilic panniculitis, bilat-
eral inguinal lymphadenopathy and peripheral blood
eosinophilia.
Case Presentation
A 25-year-old man presented with bilateral inguinal
lymphadenopathy. He was suffering from frequent
attacks of asthma for 2 years, and Reynaud phenomenon
for a few months.
Laboratory findings included a leukocyte count of
13850/mm
3 (Neutrophils: 4890 Lymphocytes: 1940 Eosi-
nophils: 5980 (43%)), Hemoglobin = 16.7 g/dL and Pla-
telet = 202000/mm
3. C-reactive protein was negative
and erythrocyte sedimentation ratio was 1 mm/h. Serum
lactate dehydrogenase level was 322 IU/L. Liver function
tests were normal. An excisional biopsy of inguinal
lymph node showed lymphoid follicles with reactive
germinal centers and well defined mantle zones, diffuse
interfollicular eosinophilic microabscesses and apparent
postcapillary venules, features associated with the diag-
nosis of KD (figure 1). He was discharged on treatment
with oral prednisolone 1 mg/kg/day. One month later a
follow up Complete blood count (CBC) showed evident
decrease in eosinophilia: Leukocyte: 12480/mm
3 (Neu-
trophil: 10750 Lymphocyte: 1390 Eosinophil: 340 (about
4%)) and the Reynaud phenomenon was improved. Pre-
dnisolone was tapered and patient followed. Two
months after tapering of prednisolone, he returned with
40% peripheral eosinophilia. He was prescribed with
cyclosporine 200 mg twice daily orally.
After starting cyclosporine, he complained of headache
and vertigo and rise in blood pressure. Renal function
tests were normal and we decreased the dose of cyclos-
porine to 50 mg twice daily. In a follow up visit three
months after the administration of cyclosporine, eosino-
philia was less than 1% and the patient’sa s t h m aw a si n
control without use of bronchodilators.
In the next visit cyclosporine was discontinued and 15
days later he developed pruritic purple-red nodular
lesions on his shins. Biopsy was taken from these lesions
and cyclosporine 50 mg twice daily restarted. The result
of skin biopsy was eosinophilic panniculitis with dense
infiltration of lymphocytes, neutrophils and eosinophils
(predominantly eosinophils) in perivascular and
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septa and nodules of fatty tissue and aggregates of eosi-
nophils between dermal collagen fibers (figure 2).
He is on a maintenance dose of 25 mg/day cyclospor-
ine while there has been no more complaint of asthma
attack, Reynaud phenomenon and skin lesions during
the past 6 months.
Discussion
Kimura’s disease was first described in 1937 by Kim and
Szeto in the Chinese literature and was later character-
ized by Kimura et al in 1948. This is a rare benign
chronic inflammatory condition presenting with pain-
less, slowly enlarging soft tissue mass, associated lym-
phadenopathy and peripheral blood eosinophilia. Soft
tissue and lymph nodes of head and neck are involved
typically. Bilateral involvement is rare. It mimics a num-
ber of lymphoproliferative and neoplastic conditions in
its presentation [1].
KD usually occurs in the younger middle aged males
between the second and third decades of life and is
most common in Asian men. The onset of KD is insi-
dious, following an indolent course, gradually increasing
in size over months or years. The overall prognosis is
good. Although spontaneous involution is rare, malig-
nant transformation has not been documented [1].
T h ee t i o l o g ya n dt h ep a t h o g e n e s i so fK Da r e
unknown. The disease is classified as a benign reactive
process. Allergic reactions, infections, and autoimmune
reactions with an aberrant immune response have been
suggested [2]. Complications such as atopic dermatitis,
allergic rhinitis, asthma, and urticaria occur among
patients.
The most common histologic features of KD include
preserved nodal architecture; follicular hyperplasia with
reactive germinal centers; well-formed mantle zones;
eosinophilic infiltrates involving the interfollicular areas,
sinusoidal areas, perinodal soft tissue, and subcutaneous
tissue; and proliferation of postcapillary venules. The
following can also be observed: proteinaceous deposits
in germinal centers, vascularization of germinal centers,
necrosis of germinal centers, polykaryocytes (Warthin-
Finkeldey-type giant cells), eosinophils in germinal cen-
ters, eosinophilic folliculolysis, eosinophilic microabs-
cesses, postcapillary venule proliferation, stromal
sclerosis, perivenular sclerosis, or small eosinophilic
granulomas. Sclerosis of variable degrees is often
observed. Immunohistochemical staining with IgE shows
a characteristic reticular staining pattern of germinal
centers [3].
The anatomic site of lymph node involvement can be
posterior auricular, cervical, inguinal (present patient),
and epitrochlear lymph nodes, salivary gland involve-
m e n th a sa l s ob e e nr e p o r t e d[ 3 ] .K Dc a na l s op r e s e n t
with middle mediastinal mass [4].
Patients almost always have marked peripheral eosino-
philia, and elevated serum IgE levels [1]. The latter was
not measured for our patient, but eosinophilia was
prominent.
KD can be associated with mesangial proliferative glo-
merulonephritis, minimal change disease and membrane
nephropathy [5,6]. Our patient had normal urine analy-
sis and serum creatinine. Associations between KD and
asthma, rash, Reynaud phenomenon [7], ulcerative coli-
tis [8], temporal arteritis [6], eosinophilic myocarditis,
lichen amyloidosus [9] and erytroderma [10], have been
reported. Our patient was affected by two of these con-
ditions, asthma and the Reynaud phenomenon. He also
had eosinophilic panniculitis which has not been
reported before.
Figure 1 Inguinal lymph node biopsy.N o t et h ed i f f u s e
interfollicular eosinophilic microabscesses in the lymph node.
Figure 2 Eosinophilic panniculitis. Dense infiltration of
lymphocytes, neutrophils and eosinophils (predominantly
eosinophils) in perivascular and periadnexal areas.
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However, treatment should aim to preserve cosmetics
and function while preventing recurrences and long-
term sequels [11]. Therapeutic options have included
surgery, radiotherapy, laser fulguration and steroids.
There is a tendency for lesions to recur when steroid
therapy is stopped. For recurrent lesions not responding
to either modality, local irradiation (25-30 cGy) has
been found effective [6]. Recent case reports have
reported cyclosporine [6], azathioprine [12], pentoxifyl-
line [11] and Imatinib [6] to be effective in the treat-
ment of KD. We treated our patient initially with
prednisolone, while cyclosporine showed effective to
maintain recovery after steroid tapering. Cyclosporine
inhibits calcium-dependent signaling pathways in tran-
scription of IL-2 gene by affecting intracellular binding
proteins. Decreased production of IL-2 inhibits T-cell
proliferation and suppresses the immune response.
Cytokines such as IL-4, IL-5 and IL-13 are said to have
a role in production of IgE by B cells that is needed for
differentiation of Th2 lymphocytes [13] and cyclosporine
is reported to decrease the level of these cytokines. Senel
et al [14] reported a combination of cyclosporine,
azathioprine and prednisolone to be successful in treat-
ment of KD and decreasing serum levels of soluble IL-2
receptor (sIL-2R), IL-4 and IL-5 consequently. Sato et al
[13] also tried cyclosporine successfully in combination
with prednisolone for treatment of an 11-year-old boy
with relapsing KD after steroid tapering. They also
showed a decrease in serum levels of sIL-2R, IL-4, IL-5,
IgE and eosinophil count. In comparison to our case,
these authors have experienced combination therapies
including cyclosporine, but we treated our patient with
cyclosporine alone after the relapse following predniso-
lone tapering. Katagiri et al [15] showed suppression of
activity of KD by cyclosporine after incomplete surgical
resection of the tumor and radiation therapy. High
levels of IL-4, IL-5 and IL-13 mRNAs, peripheral blood
eosinophil count and serum IgE level decreased after
surgery and radiation and continued to decrease during
cyclosporine therapy. It is suggested that Th2 lympho-
cytes and related cytokines are important in induction
of eosinophilia and KD while cyclosporine acts against
this condition by inhibiting Th2 cells and the cytokines
[13].
Most of the case reports accepted local surgical exci-
sion as treatment of choice to preserve cosmetics and to
relief of other symptoms. The exception is KD asso-
ciated with nephritic syndrome, for which systemic
treatment such as oral steroids is recommended. In the
present case, lymphadenopathies were bilateral, of which
only one on the left side was resected for diagnosis, and
complete resection seemed impossible. On the other
hand, he had Reynaud phenomenon and asthma as
signs of a systemic disorder, making systemic therapy
reasonable.
Conclusions
There are some points of importance in this present
case. Primarily it should be taken to consideration that
unresponsive or steroid dependent asthma may be initial
m a n i f e s t a t i o no fa nu n d e r l y i n gc o n d i t i o ns u c ha sK D .
There are a few case studies showing cyclosporine to be
useful in treatment of KD unresponsive to corticoster-
oids. We also observed dramatic response to cyclospor-
ine in our patient who was dependent to high doses of
steroid and kept our patient off steroids. We also
reported eosinophilic panniculitis as a process in the
course of KD that has not been reported previously.
Although panniculitis occurred within a short time after
discontinuation of cyclosporine and disappeared after
reinstitution of cyclosporine, there is no certainty
whether this condition is a manifestation of KD or just
a coincidence. We hope this information to be useful in
diagnosis and management of KD in other cases.
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